Sterne, Kessler, Goldstein & Fox published an article for Life Sciences IP Review by Sterne Kessler Director Paul Calvo exploring how the rise of China-origin biotech assets is reshaping licensing conversations.

Sterne, Kessler, Goldstein & Fox is a full-service intellectual property law firm that provides innovative solutions tailored to your business and industry. Since our founding in 1978, we have grown to become one of the largest IP specialty law firms in the United States. We collaborate across the full spectrum of IP to deliver real results for our clients—from patent and trademark prosecution, to patent litigation in federal district and appellate courts, strategic IP counseling, due diligence, and post-grant proceedings before the Patent Trial and Appeal Board. Our team includes attorneys, patent agents, and technical specialists with 100+ advanced degrees, including 60+ Ph.D.s,, in science and engineering disciplines. We work with the world’s leading innovators and brands, ranging from individual inventors and startups to renowned universities and Fortune 500 companies. We are proud to be one of the most highly regarded IP specialty law firms, and we have cultivated an environment that is welcoming, inclusive, and intellectually stimulating. And we’re honored that our attorneys and staff have voted Sterne Kessler as a Washington Post “Top Workplace” for 12 years running.

Founded 1978